Kristen Young

Interests

No activities entered.

Courses

No activities entered.

Scholarly Contributions

Journals/Publications

• Castro-Gutierrez, A., Young, K., & Bermas, B. L. (2021). Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Obstetric Antiphospholipid Syndrome. The Medical clinics of North America, 105(2), 341-353.
  More info

  Management of women with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and obstetric antiphospholipid syndrome (APS) during pregnancy presents unique clinical challenges. Women with both RA and SLE can have disease flares during pregnancy, leading to pregnancy complications, such as preeclampsia, small-for-gestational-age infants, and preterm delivery. Disease should be under control prior to conception. Women with obstetric APS need to be anticoagulated during pregnancy. Many but not all antirheumatic medications can be used during pregnancy and lactation.
• Sattui, S. E., Liew, J. W., Kennedy, K., Sirotich, E., Putman, M., Moni, T. T., Akpabio, A., Alpízar-Rodríguez, D., Berenbaum, F., Bulina, I., Conway, R., Singh, A. D., Duff, E., Durrant, K. L., Gheita, T. A., Hill, C. L., Howard, R. A., Hoyer, B. F., Hsieh, E., , El Kibbi, L., et al. (2021). Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. RMD open, 7(3).
  More info

  We describe the early experiences of adults with systemic rheumatic disease who received the COVID-19 vaccine.
• Cravero, A. L., Kim, N. J., Feld, L. D., Berry, K., Rabiee, A., Bazarbashi, N., Bassin, S., Lee, T. H., Moon, A. M., Qi, X., Liang, P. S., Aby, E. S., Khan, M. Q., Young, K. J., Patel, A., Wijarnpreecha, K., Kobeissy, A., Hashim, A., Houser, A., & Ioannou, G. N. (2020). Impact of exposure to patients with COVID-19 on residents and fellows: an international survey of 1420 trainees. Postgraduate medical journal.
  More info

  To determine how self-reported level of exposure to patients with novel coronavirus 2019 (COVID-19) affected the perceived safety, training and well-being of residents and fellows.
• Graef, E. R., Liew, J. W., Putman, M. S., Simard, J. F., Sirotich, E., Berenbaum, F., Duarte-García, A., Grainger, R., Harrison, C., Konig, M. F., Korsten, P., Proulx, L., Richards, D. P., Robinson, P. C., Sattui, S. E., Ugarte-Gil, M. F., Young, K. J., Kim, A. H., Sparks, J. A., & , C. G. (2020). : hydroxychloroquine, COVID-19 and the role of the rheumatologist. Annals of the rheumatic diseases, 79(6), 734-736.
• Kilian, A., Chock, Y. P., Huang, I. J., Graef, E. R., Upton, L. A., Khilnani, A., Krupnikova, S. D., Almaghlouth, I., Cappelli, L. C., Fernandez-Ruiz, R., Frankel, B. A., Frankovich, J., Harrison, C., Kumar, B., Monga, K., Vega, J. A., Singh, N., Sparks, J. A., Sullo, E., , Young, K. J., et al. (2020). Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review. Seminars in arthritis and rheumatism, 50(5), 1191-1201.
  More info

  COVID-19 is an acute respiratory viral infection that threatens people worldwide, including people with rheumatic disease, although it remains unclear to what extent various antirheumatic disease therapies increase susceptibility to complications of viral respiratory infections.
• Sattui, S. E., Liew, J. W., Graef, E. R., Coler-Reilly, A., Berenbaum, F., Duarte-García, A., Harrison, C., Konig, M. F., Korsten, P., Putman, M. S., Robinson, P. C., Sirotich, E., Ugarte-Gil, M. F., Webb, K., Young, K. J., Kim, A. H., & Sparks, J. A. (2020). Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. Expert review of clinical immunology, 16(7), 659-666.
  More info

  Several months into the COVID-19 pandemic, safe and effective treatments against this global health disaster have yet to be identified. Clinical research trials around the world are underway testing a wide array of possible medications. In particular, the off-label use of hydroxychloroquine for COVID-19 prophylaxis and treatment has created many unprecedented challenges for the scientific community and the public.
• Young, K., Doernberg, S. B., Snedecor, R. F., & Mallin, E. (2019). Things We Do For No Reason: Contact Precautions for MRSA and VRE. Journal of hospital medicine, 14(3), 178-180.

Poster Presentations

• Young, K., & Bergin, C. (2018, April). Non-Articular Felty’s Syndrome as the Initial Presentation of Rheumatoid Arthritis. Hospital Medicine 2018. Orlando, FL: Society of Hospital Medicine.